Titel	Veröffentlichungsdatum	Sprache	Zitate
Nitric oxide synthase activity in human breast cancer	1995/07/01	English	402
KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer	2009/07/14	English	399
Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma	2014/06/17	English	399
A New Theory on the Cancer-inducing Mechanism	1953/03/01	English	395
PTEN loss of expression predicts cetuximab efficacy in metastatic colorectal cancer patients	2007/10/01	English	393
The role of JAK/STAT signalling in the pathogenesis, prognosis and treatment of solid tumours	2015/07/01	English	390
TAMeless traitors: macrophages in cancer progression and metastasis	2017/10/24	English	388
The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations	2005/05/01	English	386
The role of endothelial-to-mesenchymal transition in cancer progression	2008/09/16	English	385
Second primary malignancies in thyroid cancer patients	2003/10/28	English	385
NK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend in vivo antitumour activity and reduce the neurotoxicity of paclitaxel	2005/03/22	English	384
Burnout and psychiatric disorder among cancer clinicians	1995/06/01	English	383
Trastuzumab-based treatment of HER2-positive breast cancer: an antibody-dependent cellular cytotoxicity mechanism?	2006/01/01	English	383
Association of perceived physician communication style with patient satisfaction, distress, cancer-related self-efficacy, and perceived control over the disease	2003/03/01	English	382
Why are tumour blood vessels abnormal and why is it important to know?	2009/02/24	English	379
Statistical aspects of prognostic factor studies in oncology	1994/06/01	English	375
A meta-analysis of alcohol drinking and cancer risk	2001/11/27	English	373
Routes to diagnosis for cancer – determining the patient journey using multiple routine data sets	2012/09/20	English	371
Physical activity and colon cancer prevention: a meta-analysis	2009/02/01	English	371
Integrins: roles in cancer development and as treatment targets	2004/02/01	English	371
Tumour-targeted nanomedicines: principles and practice	2008/07/22	English	370
An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study	2011/01/25	English	369
Assessment of morbidity from complete axillary dissection	1992/07/01	English	364
A double-blind placebo-controlled, randomised study comparing gemcitabine and marimastat with gemcitabine and placebo as first line therapy in patients with advanced pancreatic cancer	2002/07/01	English	360
De novo fatty-acid synthesis and related pathways as molecular targets for cancer therapy	2009/04/07	English	360
Cellular accumulation of the anticancer agent cisplatin: A review	1993/06/01	English	360
Exosomal microRNA in serum is a novel biomarker of recurrence in human colorectal cancer	2015/06/09	English	358
Chronic immune activation and inflammation as the cause of malignancy	2001/08/01	English	357
Oncogenic KRAS signalling in pancreatic cancer	2014/04/22	English	351
Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer	2013/06/25	English	350